MLICM
SMTI icon

Metropolitan Life Insurance Company (MetLife)’s Sanara MedTech SMTI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-222
Closed -$8.21K – 1806
2024
Q1 		$8.21K Hold
222
– – ﹤0.01% 2196
2023
Q4 		$9.12K Hold
222
– – ﹤0.01% 2210
2023
Q3 		$6.91K Hold
222
– – ﹤0.01% 2362
2023
Q2 		$8.9K Buy
+222
New +$9.08K ﹤0.01% 2354

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SMTI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sanara MedTech (SMTI) in Q2 2024, closing a stake of 222 shares — an estimated $8.21K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SMTI in Q2 2023 and held it in 4 quarters. The position peaked at $9.12K in Q4 2023. 40 funds tracked by Wall St. Rank hold SMTI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sanara MedTech position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 222 Sanara MedTech shares in Q2 2024, an estimated $8.21K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sanara MedTech in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sanara MedTech position peaked at $9.12K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.